Rapid CommunicationAccelerated CommunicationA
Identification, Molecular Cloning, Expression, and Characterization of a Cysteinyl Leukotriene Receptor
Henry M. Sarau, Robert S. Ames, Jon Chambers, Catherine Ellis, Nabil Elshourbagy, James J. Foley, Dulcie B. Schmidt, Roseanna M. Muccitelli, Owen Jenkins, Paul R. Murdock, Nicole C. Herrity, Wendy Halsey, Ganesh Sathe, Alison I. Muir, Parvathi Nuthulaganti, George M. Dytko, Peter T. Buckley, Shelagh Wilson, Derk J. Bergsma and Douglas W.P. Hay
Molecular Pharmacology September 1999, 56 (3) 657-663; DOI: https://doi.org/10.1124/mol.56.3.657
Henry M. Sarau
Departments of Pulmonary Pharmacology, Molecular Biology, Gene Expression Sciences, Molecular Screening, Genetic Technologies, Renal Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania; and New Frontiers Science Park, Harlow, Essex, England
Robert S. Ames
Departments of Pulmonary Pharmacology, Molecular Biology, Gene Expression Sciences, Molecular Screening, Genetic Technologies, Renal Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania; and New Frontiers Science Park, Harlow, Essex, England
Jon Chambers
Departments of Pulmonary Pharmacology, Molecular Biology, Gene Expression Sciences, Molecular Screening, Genetic Technologies, Renal Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania; and New Frontiers Science Park, Harlow, Essex, England
Catherine Ellis
Departments of Pulmonary Pharmacology, Molecular Biology, Gene Expression Sciences, Molecular Screening, Genetic Technologies, Renal Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania; and New Frontiers Science Park, Harlow, Essex, England
Nabil Elshourbagy
Departments of Pulmonary Pharmacology, Molecular Biology, Gene Expression Sciences, Molecular Screening, Genetic Technologies, Renal Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania; and New Frontiers Science Park, Harlow, Essex, England
James J. Foley
Departments of Pulmonary Pharmacology, Molecular Biology, Gene Expression Sciences, Molecular Screening, Genetic Technologies, Renal Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania; and New Frontiers Science Park, Harlow, Essex, England
Dulcie B. Schmidt
Departments of Pulmonary Pharmacology, Molecular Biology, Gene Expression Sciences, Molecular Screening, Genetic Technologies, Renal Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania; and New Frontiers Science Park, Harlow, Essex, England
Roseanna M. Muccitelli
Departments of Pulmonary Pharmacology, Molecular Biology, Gene Expression Sciences, Molecular Screening, Genetic Technologies, Renal Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania; and New Frontiers Science Park, Harlow, Essex, England
Owen Jenkins
Departments of Pulmonary Pharmacology, Molecular Biology, Gene Expression Sciences, Molecular Screening, Genetic Technologies, Renal Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania; and New Frontiers Science Park, Harlow, Essex, England
Paul R. Murdock
Departments of Pulmonary Pharmacology, Molecular Biology, Gene Expression Sciences, Molecular Screening, Genetic Technologies, Renal Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania; and New Frontiers Science Park, Harlow, Essex, England
Nicole C. Herrity
Departments of Pulmonary Pharmacology, Molecular Biology, Gene Expression Sciences, Molecular Screening, Genetic Technologies, Renal Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania; and New Frontiers Science Park, Harlow, Essex, England
Wendy Halsey
Departments of Pulmonary Pharmacology, Molecular Biology, Gene Expression Sciences, Molecular Screening, Genetic Technologies, Renal Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania; and New Frontiers Science Park, Harlow, Essex, England
Ganesh Sathe
Departments of Pulmonary Pharmacology, Molecular Biology, Gene Expression Sciences, Molecular Screening, Genetic Technologies, Renal Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania; and New Frontiers Science Park, Harlow, Essex, England
Alison I. Muir
Departments of Pulmonary Pharmacology, Molecular Biology, Gene Expression Sciences, Molecular Screening, Genetic Technologies, Renal Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania; and New Frontiers Science Park, Harlow, Essex, England
Parvathi Nuthulaganti
Departments of Pulmonary Pharmacology, Molecular Biology, Gene Expression Sciences, Molecular Screening, Genetic Technologies, Renal Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania; and New Frontiers Science Park, Harlow, Essex, England
George M. Dytko
Departments of Pulmonary Pharmacology, Molecular Biology, Gene Expression Sciences, Molecular Screening, Genetic Technologies, Renal Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania; and New Frontiers Science Park, Harlow, Essex, England
Peter T. Buckley
Departments of Pulmonary Pharmacology, Molecular Biology, Gene Expression Sciences, Molecular Screening, Genetic Technologies, Renal Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania; and New Frontiers Science Park, Harlow, Essex, England
Shelagh Wilson
Departments of Pulmonary Pharmacology, Molecular Biology, Gene Expression Sciences, Molecular Screening, Genetic Technologies, Renal Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania; and New Frontiers Science Park, Harlow, Essex, England
Derk J. Bergsma
Departments of Pulmonary Pharmacology, Molecular Biology, Gene Expression Sciences, Molecular Screening, Genetic Technologies, Renal Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania; and New Frontiers Science Park, Harlow, Essex, England
Douglas W.P. Hay
Departments of Pulmonary Pharmacology, Molecular Biology, Gene Expression Sciences, Molecular Screening, Genetic Technologies, Renal Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania; and New Frontiers Science Park, Harlow, Essex, England
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Rapid CommunicationAccelerated CommunicationA
Identification, Molecular Cloning, Expression, and Characterization of a Cysteinyl Leukotriene Receptor
Henry M. Sarau, Robert S. Ames, Jon Chambers, Catherine Ellis, Nabil Elshourbagy, James J. Foley, Dulcie B. Schmidt, Roseanna M. Muccitelli, Owen Jenkins, Paul R. Murdock, Nicole C. Herrity, Wendy Halsey, Ganesh Sathe, Alison I. Muir, Parvathi Nuthulaganti, George M. Dytko, Peter T. Buckley, Shelagh Wilson, Derk J. Bergsma and Douglas W.P. Hay
Molecular Pharmacology September 1, 1999, 56 (3) 657-663; DOI: https://doi.org/10.1124/mol.56.3.657
Rapid CommunicationAccelerated CommunicationA
Identification, Molecular Cloning, Expression, and Characterization of a Cysteinyl Leukotriene Receptor
Henry M. Sarau, Robert S. Ames, Jon Chambers, Catherine Ellis, Nabil Elshourbagy, James J. Foley, Dulcie B. Schmidt, Roseanna M. Muccitelli, Owen Jenkins, Paul R. Murdock, Nicole C. Herrity, Wendy Halsey, Ganesh Sathe, Alison I. Muir, Parvathi Nuthulaganti, George M. Dytko, Peter T. Buckley, Shelagh Wilson, Derk J. Bergsma and Douglas W.P. Hay
Molecular Pharmacology September 1, 1999, 56 (3) 657-663; DOI: https://doi.org/10.1124/mol.56.3.657
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement